128 related articles for article (PubMed ID: 6871866)
1. Changes in the host lymphocyte subsets during chemical carcinogenesis.
Brodt P; Lala PK
Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific immune responsiveness of the tumor-bearing host.
Burk MW; Yu S; McKhann CF
Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
[TBL] [Abstract][Full Text] [Related]
3. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
Dye ES
J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
[TBL] [Abstract][Full Text] [Related]
4. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts.
Krueger JG; Segal RA; Moyer RC
Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues.
Wei WZ; Malone K; Mahoney K; Heppner G
Cancer Res; 1986 Jun; 46(6):2680-5. PubMed ID: 3084071
[TBL] [Abstract][Full Text] [Related]
6. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
[TBL] [Abstract][Full Text] [Related]
7. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
Ruppert B; Blazar B; Medina D; Heppner G
J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
[TBL] [Abstract][Full Text] [Related]
8. Studies on T and B lymphocytes in rats bearing methylcholanthrene-induced tumor.
Klobusická M; Kalafut F; Novotná L
Neoplasma; 1978; 25(6):667-77. PubMed ID: 313020
[TBL] [Abstract][Full Text] [Related]
9. Interaction in culture between mouse ascites mammary carcinoma (MM2) cells and lymphoid cells of isologous mice.
Katsuta H; Ashikawa K; Takaoka T
Jpn J Exp Med; 1975 Jun; 45(3):223-9. PubMed ID: 1177362
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic inhibitory activity of regional lymph node cells in the mouse isografted with methylcholanthrene-induced tumor.
Orita K; Onishi N; Kunisada K; Konaga E; Kokumai Y
Acta Med Okayama; 1975 Jun; 29(3):183-7. PubMed ID: 127512
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of some immunological and biochemical changes of immunocompetent cells during tumor growth in rats.
Koníková E; Hrivnáková A; Babusíková O
Neoplasma; 1986; 33(5):583-93. PubMed ID: 3785465
[TBL] [Abstract][Full Text] [Related]
12. The antimetastatic function of concomitant antitumor immunity. I. Host Ly-1+2+ effector T cells prevent the enumeration of metastatic tumor cells in a biological assay.
Dye SE
J Immunol; 1986 Feb; 136(4):1504-9. PubMed ID: 3080525
[TBL] [Abstract][Full Text] [Related]
13. A time factor in the success or failure of immune rejection of transplanted tumors.
Vaage J
Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor.
Brodt P; Gordon J
J Immunol; 1978 Jul; 121(1):359-62. PubMed ID: 307580
[TBL] [Abstract][Full Text] [Related]
15. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
Blazar BA; Miller FR; Heppner GH
J Immunol; 1978 Jun; 120(6):1887-91. PubMed ID: 659883
[TBL] [Abstract][Full Text] [Related]
16. Morphological observations during developing concomitant immunity against a C3H/He mammary tumor.
Vaage J; Pepin KG
Cancer Res; 1985 Feb; 45(2):659-66. PubMed ID: 3967241
[TBL] [Abstract][Full Text] [Related]
17. Depression of host versus graft immunity and stimulation of tumor growth following partial hepatectomy.
Pliskin ME
Cancer Res; 1976 May; 36(5):1659-63. PubMed ID: 1268827
[TBL] [Abstract][Full Text] [Related]
18. [Impairment of several forms of lymphocyte and hematopoietic stem cell interaction during tumor growth].
Khaitov RM; Gambarov SS; Petrov RV; Norimov ASh
Vopr Onkol; 1976; 22(3):49-54. PubMed ID: 945641
[TBL] [Abstract][Full Text] [Related]
19. Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.
Pope BL; Whitney RB; Levy JG; Kilburn DG
J Immunol; 1976 May; 116(5):1342-6. PubMed ID: 1270799
[TBL] [Abstract][Full Text] [Related]
20. Tumor immunoprophylaxis in mice using glutaraldehyde-treated syngeneic tumor cells.
Frost P; Sanderson CJ
Cancer Res; 1975 Oct; 35(10):2646-50. PubMed ID: 50879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
